These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9271825)
1. Proteasome subunits, low-molecular-mass polypeptides 2 and 7 are hyperexpressed by target cells in autoimmune thyroid disease but not in insulin-dependent diabetes mellitus: implications for autoimmunity. Vives-Pi M; Vargas F; James RF; Trowsdale J; Costa M; Sospedra M; Somoza N; Obiols G; Tampé R; Pujol-Borrell R Tissue Antigens; 1997 Aug; 50(2):153-63. PubMed ID: 9271825 [TBL] [Abstract][Full Text] [Related]
2. Antigen processing and autoimmunity. Evaluation of mRNA abundance and function of HLA-linked genes. Fu Y; Yan G; Shi L; Faustman D Ann N Y Acad Sci; 1998 Apr; 842():138-55. PubMed ID: 9599304 [TBL] [Abstract][Full Text] [Related]
3. Hyperexpression of transporter in antigen processing-1 (TAP-1) in thyroid glands affected by autoimmunity: a contributing factor to the breach of tolerance to thyroid antigens? Sospedra M; Tolosa E; Armengol P; Ashhab Y; Urlinger S; Lucas-Martin A; Foz-Sala M; Jaraquemada D; Pujol-Borrell R Clin Exp Immunol; 1997 Jul; 109(1):98-106. PubMed ID: 9218831 [TBL] [Abstract][Full Text] [Related]
4. Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Deng GY; Muir A; Maclaren NK; She JX Am J Hum Genet; 1995 Feb; 56(2):528-34. PubMed ID: 7847389 [TBL] [Abstract][Full Text] [Related]
5. Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes. Li CW; Osman R; Menconi F; Concepcion ES; Tomer Y J Autoimmun; 2017 Jan; 76():1-9. PubMed ID: 27670087 [TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity. Moriguchi M; Noso S; Kawabata Y; Yamauchi T; Harada T; Komaki K; Babaya N; Hiromine Y; Ito H; Yamagata S; Murata K; Higashimoto T; Park C; Yamamoto A; Ohno Y; Ikegami H Metabolism; 2011 Jun; 60(6):761-6. PubMed ID: 20825955 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Takao Y; Yamaguchi Y; Akazawa S; Nagataki S Diabetes; 1994 Jan; 43(1):80-6. PubMed ID: 8262321 [TBL] [Abstract][Full Text] [Related]
9. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease. Yoshikawa N; Morita T; Arreaza G; Resetkova E; Mukuta T; Volpé R Clin Invest Med; 1995 Apr; 18(2):91-8. PubMed ID: 7788961 [TBL] [Abstract][Full Text] [Related]
10. The major-histocompatibility-complex-encoded beta-type proteasome subunits LMP2 and LMP7. Evidence that LMP2 and LMP7 are synthesized as proproteins and that cellular levels of both mRNA and LMP-containing 20S proteasomes are differentially regulated. Frentzel S; Kuhn-Hartmann I; Gernold M; Gött P; Seelig A; Kloetzel PM Eur J Biochem; 1993 Aug; 216(1):119-26. PubMed ID: 8365398 [TBL] [Abstract][Full Text] [Related]
11. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus. Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547 [TBL] [Abstract][Full Text] [Related]
12. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation. Yewdell J; Lapham C; Bacik I; Spies T; Bennink J J Immunol; 1994 Feb; 152(3):1163-70. PubMed ID: 8301122 [TBL] [Abstract][Full Text] [Related]
13. Expression of transporter associated with antigen processing-1 in the endocrine cells of human pancreatic islets: effect of cytokines and evidence of hyperexpression in IDDM. Vives-Pi M; Armengol MP; Alcalde L; Costa M; Somoza N; Vargas F; Jaraquemada D; Pujol-Borrell R Diabetes; 1996 Jun; 45(6):779-88. PubMed ID: 8635653 [TBL] [Abstract][Full Text] [Related]
15. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies. Lucas-Martin A; Foz-Sala M; Todd I; Bottazzo GF; Pujol-Borrell R J Clin Endocrinol Metab; 1988 Feb; 66(2):367-75. PubMed ID: 3276724 [TBL] [Abstract][Full Text] [Related]
16. Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes. Richardson SJ; Rodriguez-Calvo T; Gerling IC; Mathews CE; Kaddis JS; Russell MA; Zeissler M; Leete P; Krogvold L; Dahl-Jørgensen K; von Herrath M; Pugliese A; Atkinson MA; Morgan NG Diabetologia; 2016 Nov; 59(11):2448-2458. PubMed ID: 27506584 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. Badenhoop K; Walfish PG; Rau H; Fischer S; Nicolay A; Bogner U; Schleusener H; Usadel KH J Clin Endocrinol Metab; 1995 Jul; 80(7):2112-7. PubMed ID: 7608264 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity. Álvarez-Sierra D; Marín-Sánchez A; Ruiz-Blázquez P; de Jesús Gil C; Iglesias-Felip C; González Ó; Casteras A; Costa RF; Nuciforo P; Colobran R; Pujol-Borrell R J Autoimmun; 2019 Sep; 103():102285. PubMed ID: 31182340 [TBL] [Abstract][Full Text] [Related]
20. The human leukocyte antigen class II gene has different contributions to autoimmune type 1 diabetes with or without autoimmune thyroid disease in the Japanese population. Katahira M; Maeda H; Tosaki T; Segawa S Diabetes Res Clin Pract; 2009 Sep; 85(3):293-7. PubMed ID: 19581015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]